Hjem › Myositis › Florida › Miami
Myositis kliniske forsøg i Miami, FL
4 studier for Myositis søger deltagere på steder i og omkring Miami (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RekruttererFase 3
- University of Miami, Miami
- University of Miami Dermatology Clinical Trials Unit, Miami
- University of Miami, Miami
- og 1 flere
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RekruttererFase 2
- Artiva Investigational Site Miami, Miami
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Nicklaus Children's Hospital, Miami
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
RekruttererFase 2/3
- Bioresearch Partner, Miami
Myositis forsøg i andre byer
- Durham, NC10 studier
- Chicago, IL6 studier
- New York City, NY6 studier
- Boston, MA6 studier
- Houston, TX5 studier
- Cedar Rapids, IA4 studier
- Dallas, TX3 studier
- Gainesville, FL3 studier
- Plantation, FL3 studier
- Orange, CA3 studier
- Ann Arbor, MI3 studier
- Charlotte, NC3 studier
Andre studier i Miami
- Brystkræft42 studier
- Kræft (alle typer)36 studier
- Ikke-småcellet lungecancer31 studier
- Prostatakræft27 studier
- Overvægt27 studier
- Akut myeloid leukæmi24 studier
- Metastatisk cancer24 studier
- Ægstockræft23 studier
- Overvægt23 studier
- Multipelt myelom21 studier
- Ulcerøs colitis21 studier
- Alzheimers sygdom20 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.